• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用空气同位素比率质谱法进行L-[1-13C]苯丙氨酸呼气试验的结果可反映肝硬化大鼠肝脏中苯丙氨酸羟化酶的活性。

Results of L-[1-13C]phenylalanine breath test with air isotope ratio mass spectrometry can reflect the activity of phenylalanine hydroxylase in cirrhotic rat liver.

作者信息

Yan Weili, Xiong Ping, Liu Zhengwei, Huang Gang

机构信息

Department of Nuclear Medicine, Renji Hospital Affiliated to Shanghai Second Medical University, Shanghai 200127, China.

出版信息

Rapid Commun Mass Spectrom. 2006;20(4):602-8. doi: 10.1002/rcm.2345.

DOI:10.1002/rcm.2345
PMID:16429477
Abstract

The L-[1-13C]phenylalanine breath test (PheBT) could potentially advance the evaluation of hepatocyte function and liver functional reserve. However, because the factors influencing PheBT results have not been clarified, the clinical application of the test has been limited. This study investigated the relationship between the parameters of PheBT, performed with air isotope ratio mass spectrometry, and the activity of phenylalanine hydroxylase (PAH), the phenylalanine metabolism rate-limiting enzyme, in rat liver, and proposes valid parameters for the assessment of liver function. Chronic injury to the liver was induced by the administration of CCl4 to male Sprague-Dawley rats for either 8 or 12 weeks. Livers from rats in the two cirrhotic groups were discolored, enlarged and roughly textured, with cells filled with fat granules of various sizes, pseudolobuli formations, and regenerated tubercles. Of the 12 parameters tested, only the unit liver weight (LW) breath test parameters, including the maximum abundance of 13C in breath (13Cmax/LW), 13C abundance in breaths 2 and 7 min after administration of L-[1-(13)C]phenylalanine (13C-phe) (13C2/LW and 13C7/LW), cumulative 13C excretion 10 and 30 min after 13C-phe administration (AUC10/LW and AUC30/LW), and the 13C excretion rate constant (PheBT-k/LW) were significantly affected in the chronic liver injury groups. There was no significant difference in the total PAH activity in liver among the three groups, but there was significant difference in unit LW PAH activity. Total PAH activity in the liver was significantly correlated with 13Cmax, 13C2, 13C7, AUC10, AUC30 and PheBT-k, while the unit LW PAH activity was significantly correlated with 13Cmax/LW, 13C2/LW, 13C7/LW, AUC10/LW, AUC30/LW and PheBT-k/LW. PheBT-k/LW was also correlated with biochemical indices that are used to assess liver function. The present findings indicate that the PheBT results based on air isotope ratio mass spectrometry can quantitatively reflect the change in total PAH activity in the livers of chronically injured rats. PheBT-k and PheBT-k/LW are the most sensitive among the test parameters, and can be used to assess liver functional reserve and hepatocyte damage at the molecular level.

摘要

L-[1-¹³C]苯丙氨酸呼气试验(PheBT)可能会推动对肝细胞功能和肝功能储备的评估。然而,由于影响PheBT结果的因素尚未明确,该试验的临床应用受到了限制。本研究调查了采用空气同位素比质谱法进行的PheBT参数与大鼠肝脏中苯丙氨酸羟化酶(PAH)活性(苯丙氨酸代谢的限速酶)之间的关系,并提出了评估肝功能的有效参数。通过给雄性Sprague-Dawley大鼠腹腔注射四氯化碳8周或12周来诱导慢性肝损伤。两个肝硬化组大鼠的肝脏变色、肿大且质地粗糙,细胞内充满大小不一的脂肪颗粒,有假小叶形成和再生结节。在测试的12个参数中,只有单位肝脏重量(LW)呼气试验参数,包括呼气中¹³C的最大丰度(¹³Cmax/LW)、注射L-[1-(¹³)C]苯丙氨酸(¹³C-苯丙氨酸)后第2分钟和第7分钟呼气中的¹³C丰度(¹³C2/LW和¹³C7/LW)、¹³C-苯丙氨酸给药后第10分钟和第30分钟的¹³C累积排泄量(AUC10/LW和AUC30/LW)以及¹³C排泄速率常数(PheBT-k/LW)在慢性肝损伤组中受到显著影响。三组肝脏中的总PAH活性无显著差异,但单位LW的PAH活性有显著差异。肝脏中的总PAH活性与¹³Cmax、¹³C2、¹³C7/AUC10、AUC30和PheBT-k显著相关,而单位LW的PAH活性与¹³Cmax/LW、¹³C2/LW、¹³C7/LW、AUC10/LW、AUC30/LW和PheBT-k/LW显著相关。PheBT-k/LW也与用于评估肝功能的生化指标相关。目前的研究结果表明,基于空气同位素比质谱法的PheBT结果可以定量反映慢性损伤大鼠肝脏中总PAH活性的变化。PheBT-k和PheBT-k/LW在测试参数中最为敏感,可用于在分子水平评估肝功能储备和肝细胞损伤。

相似文献

1
Results of L-[1-13C]phenylalanine breath test with air isotope ratio mass spectrometry can reflect the activity of phenylalanine hydroxylase in cirrhotic rat liver.采用空气同位素比率质谱法进行L-[1-13C]苯丙氨酸呼气试验的结果可反映肝硬化大鼠肝脏中苯丙氨酸羟化酶的活性。
Rapid Commun Mass Spectrom. 2006;20(4):602-8. doi: 10.1002/rcm.2345.
2
[13C] phenylalanine breath test and hepatic phenylalanine metabolism enzymes in cirrhotic rats.肝硬化大鼠的[13C]苯丙氨酸呼气试验及肝脏苯丙氨酸代谢酶
Eur J Clin Invest. 2005 Oct;35(10):644-52. doi: 10.1111/j.1365-2362.2005.01566.x.
3
L-[1-13C] phenylalanine breath test results reflect the activity of phenylalanine hydroxylase in carbon tetrachloride acute injured rat liver.L-[1-¹³C]苯丙氨酸呼气试验结果反映了四氯化碳急性损伤大鼠肝脏中苯丙氨酸羟化酶的活性。
Life Sci. 2006 Jan 18;78(8):838-43. doi: 10.1016/j.lfs.2005.05.073. Epub 2005 Sep 1.
4
Recovery of liver function in two-third partial hepatectomized rats evaluated by L-[1-13C]phenylalanine breath test.通过L-[1-¹³C]苯丙氨酸呼气试验评估三分之二肝部分切除大鼠的肝功能恢复情况。
Surgery. 2002 Nov;132(5):849-56. doi: 10.1067/msy.2002.127947.
5
L-[1-13C] phenylalanine breath test reflects phenylalanine hydroxylase activity of the whole liver.
J Surg Res. 2003 Jun 1;112(1):38-42. doi: 10.1016/s0022-4804(03)00135-5.
6
Utility of a 13C-methacetin breath test in evaluating hepatic injury in rats.13C-美沙西汀呼气试验在评估大鼠肝损伤中的应用
J Gastroenterol Hepatol. 2008 Nov;23(11):1762-8. doi: 10.1111/j.1440-1746.2008.05431.x.
7
Phenylalanine breath test as a method to evaluate hepatic dysfunction in obstructive jaundice.苯丙氨酸呼气试验作为评估梗阻性黄疸肝功能障碍的一种方法。
J Surg Res. 2006 Jan;130(1):119-23. doi: 10.1016/j.jss.2005.08.015. Epub 2005 Oct 13.
8
Evaluation of 13C-phenylalanine and 13C-tyrosine breath tests for the measurement of hepatocyte functional capacity in patients with liver cirrhosis.
Chem Pharm Bull (Tokyo). 2001 Dec;49(12):1507-11. doi: 10.1248/cpb.49.1507.
9
13C-breath tests in hepatology (cytosolic liver function).肝病学中的13C呼气试验(胞质肝功能)
Eur Rev Med Pharmacol Sci. 2004 Jan-Feb;8(1):47-9.
10
Validity of 13C-phenylalanine breath test to evaluate functional capacity of hepatocyte in patients with liver cirrhosis and acute hepatitis.13C-苯丙氨酸呼气试验评估肝硬化和急性肝炎患者肝细胞功能的有效性。
Aliment Pharmacol Ther. 2005 Apr 1;21(7):851-9. doi: 10.1111/j.1365-2036.2005.02409.x.

引用本文的文献

1
Innovative strategies to treat protein misfolding in inborn errors of metabolism: pharmacological chaperones and proteostasis regulators.治疗先天性代谢缺陷中蛋白质错误折叠的创新策略:药理学伴侣分子和蛋白质稳态调节剂。
J Inherit Metab Dis. 2014 Jul;37(4):505-23. doi: 10.1007/s10545-014-9701-z. Epub 2014 Apr 1.